Innovative Approaches to Tooth Regrowth: A New Hope
Written on
Chapter 1: Understanding Tooth Loss
Tooth loss is a widespread issue impacting individuals across diverse demographics. The World Health Organization reports that 7% of people aged 20 and older experience edentulism, while over 23% of those over 60 have lost all their teeth.
Currently, the available solutions for replacing missing teeth include removable dentures, dental bridges, and implants. Unfortunately, none of these options replicate the natural function and feel of real teeth. This gap in dental care has driven researchers for decades to explore methods for regenerating human teeth, and recent developments have shown promising results.
Section 1.1: Breakthrough Discovery
A significant advancement has emerged from Japan, where Toregem Biopharma, in collaboration with Kyoto University, has created a novel drug inspired by Dr. Katsu Takahashi's research. This innovative drug aims to stimulate the regrowth of lost human teeth.
How does this drug function? It leverages the natural process of tooth development. Infants are born with tooth buds that mature into teeth, and in some adults, undeveloped tooth buds persist, providing a foundation for natural tooth regrowth. This drug harnesses that potential.
Subsection 1.1.1: The Mechanism Behind the Drug
This medication interacts with the uterine sensitization associated gene-1 (USAG-1) (Ravi et al., 2023), which is found in odontogenic epithelial cells. This gene serves as an antagonist to bone morphogenic proteins and certain glycoproteins in the Wnt-signaling pathway. Notably, studies indicate that mice lacking the USAG-1 gene develop extra teeth (Murashima-Suginami et al., 2007; 2008). In a 2018 experiment, ferrets also grew new teeth after being administered this drug.
The research team intends to initiate clinical trials in 2025, focusing on children aged 2 to 5 with anodontia—those born without some teeth. A single dose of the drug will be injected to encourage tooth formation, with plans to extend its application to adults seeking to regenerate lost teeth.
Section 1.2: The Vision Behind the Innovation
For Honoka Kiso, D.D.S., Ph.D., and President of Toregem Biopharma, the inspiration for this tooth regrowth treatment stemmed from her personal experience with a bone disease that caused tooth loss during her youth. “I wanted to investigate the causes of my condition and discover how to regenerate lost teeth. Our primary aim at Toregem Biopharma is to assist patients with congenital tooth loss who do not develop permanent tooth buds due to genetic factors. Ultimately, we aspire to provide advanced, scientifically-based solutions for tooth growth utilizing patients’ own tissues,” Kiso stated.
Chapter 2: The Future of Tooth Regeneration
“Missing teeth in a child can hinder the development of their jawbone,” remarked Katsu Takahashi, co-founder of Toregem Biopharma and leader in dentistry and oral surgery at Kitano Hospital in Osaka. Additionally, tooth loss can negatively impact a person’s smile, facial aesthetics, and self-esteem.
With the advent of this new drug, the prospect of regenerating lost or congenitally absent teeth is closer than ever. Ongoing research in this field is anticipated to uncover further possibilities in dental tissue regeneration, potentially reducing the reliance on prosthetic replacements.
The first video titled "Why Humans Can't Regrow Teeth" explores the biological limitations that prevent natural tooth regeneration in humans, detailing the challenges and advancements in dental science.
The second video, "How University of Washington Scientists Use Stem Cells to Regenerate Tooth Enamel," delves into innovative methods scientists are employing to harness stem cells for tooth regeneration, providing insights into future dental treatments.
References
Murashima-Suginami, A., Takahashi, K., Kawabata, T., Sakata, T., Tsukamoto, H., Sugai, M., Yanagita, M., Shimizu, A., Sakurai, T. & Slavkin, H. C. 2007. Rudiment incisors survive and erupt as supernumerary teeth as a result of USAG-1 abrogation. Biochemical and Biophysical Research Communications, 359, 549–555.
Murashima-Suginami, A., Takahashi, K., Sakata, T., Tsukamoto, H., Sugai, M., Yanagita, M., Shimizu, A., Sakurai, T., Slavkin, H. C. & Bessho, K. 2008. Enhanced BMP signaling results in supernumerary tooth formation in USAG-1 deficient mice. Biochemical and Biophysical Research Communications, 369, 1012–1016.
Ravi, V., Murashima-Suginami, A., Kiso, H., Tokita, Y., Huang, C. L., Bessho, K., Takagi, J., Sugai, M., Tabata, Y. & Takahashi, K. 2023. Advances in tooth agenesis and tooth regeneration. Regenerative Therapy, 22, 160–168.
Thank You for Reading!